# amgen inc Amgen Inc. has acquired cancer drug developer Dark Blue Therapeutics for up to $840 million, bolstering its oncology portfolio. Social media buzz highlights Amgen's stock ($AMGN) with a positive outlook based on technicals ahead of upcoming earnings. ### About amgen inc Amgen Inc. is a biotechnology company focused on discovering, developing, manufacturing, and delivering innovative human therapeutics. ### Engagements: [---] (24h)  [Engagements 24-Hour Time-Series Raw Data](/topic/amgen-inc/time-series/interactions.tsv) Current Value: [---] Daily Average: [-----] [--] Month: [------] -96% [--] Months: [---------] +268% [--] Year: [---------] -24% 1-Year High: [-------] on 2025-12-27 1-Year Low: [--] on 2025-08-09 Engagements by network (24h): News: [--] TikTok: [--] Reddit: [--] X: [---] YouTube: [--] ### Mentions: [--] (24h)  [Mentions 24-Hour Time-Series Raw Data](/topic/amgen-inc/time-series/posts_active.tsv) Current Value: [--] Daily Average: [--] 1-Year High: [--] on 2025-12-27 1-Year Low: [--] on 2025-08-08 Mentions by network (24h): News: [--] TikTok: [--] Reddit: [--] X: [--] YouTube: [--] ### Creators: [--] (24h)  [Creators 24-Hour Time-Series Raw Data](/topic/amgen-inc/time-series/contributors_active.tsv) [--] unique social accounts have posts mentioning amgen inc in the last [--] hours which is up 58% from [--] in the previous [--] hours Daily Average: [--] 1-Year High: [--] on 2025-03-21 1-Year Low: [--] on 2025-08-08 ### Sentiment: 100%  [Sentiment 24-Hour Time-Series Raw Data](/topic/amgen-inc/time-series/sentiment.tsv) Current Value: 100% Daily Average: 78% [--] Month: 85% +3% [--] Months: 85% +5% [--] Year: 85% +8% 1-Year High: 100% on 2025-03-14 1-Year Low: 25% on 2025-12-09 Most Supportive Themes: - Amgen's Oncology Expansion: (6%) Amgen Inc. is expanding its oncology treatments through strategic acquisitions, as evidenced by the recent deal with Dark Blue Therapeutics. - Positive Stock Outlook: (1%) Social media posts highlight Amgen Inc. ($AMGN) as a strong watch for the upcoming week, citing technical indicators like base breakout, strong volume, and potential bull flag formation. Most Critical Themes: Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing
Amgen Inc. has acquired cancer drug developer Dark Blue Therapeutics for up to $840 million, bolstering its oncology portfolio. Social media buzz highlights Amgen's stock ($AMGN) with a positive outlook based on technicals ahead of upcoming earnings.
Amgen Inc. is a biotechnology company focused on discovering, developing, manufacturing, and delivering innovative human therapeutics.
Engagements 24-Hour Time-Series Raw Data
Current Value: [---]
Daily Average: [-----]
[--] Month: [------] -96%
[--] Months: [---------] +268%
[--] Year: [---------] -24%
1-Year High: [-------] on 2025-12-27
1-Year Low: [--] on 2025-08-09
Engagements by network (24h): News: [--] TikTok: [--] Reddit: [--] X: [---] YouTube: [--]
Mentions 24-Hour Time-Series Raw Data
Current Value: [--]
Daily Average: [--]
1-Year High: [--] on 2025-12-27
1-Year Low: [--] on 2025-08-08
Mentions by network (24h): News: [--] TikTok: [--] Reddit: [--] X: [--] YouTube: [--]
Creators 24-Hour Time-Series Raw Data
[--] unique social accounts have posts mentioning amgen inc in the last [--] hours which is up 58% from [--] in the previous [--] hours
Daily Average: [--]
1-Year High: [--] on 2025-03-21
1-Year Low: [--] on 2025-08-08
Sentiment 24-Hour Time-Series Raw Data
Current Value: 100%
Daily Average: 78%
[--] Month: 85% +3%
[--] Months: 85% +5%
[--] Year: 85% +8%
1-Year High: 100% on 2025-03-14
1-Year Low: 25% on 2025-12-09
Most Supportive Themes:
Most Critical Themes:
Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing
/topic/amgen-inc